<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="ribavirin/PMC7473106/results/search/drugs/results.xml">
  <result pre="is involved in T-cell co-stimulatory activation via its association with" exact="adenosine" post="deaminase (ADA), caveolin-1, the caspase recruitment domain-containing membrane-associated guanylate"/>
  <result pre="of Th1, Th2, and Th17 lymphocytes [59]. Clinical treatment with" exact="sitagliptin" post="reduced the number of circulating CD4+ T cells, Th17"/>
  <result pre="type 2 diabetes [60]. Inhibition of DPP4 by siRNA or" exact="sitagliptin" post="diminished the effects of the MERS-CoV S protein on"/>
  <result pre="agents, have been proposed [70]. The broad-spectrum antiviral remdesivir and" exact="chloroquine" post="have been effective for viral control in vitro. Remdesivir"/>
  <result pre="been effective for viral control in vitro. Remdesivir is an" exact="adenosine" post="analogue which targets the RNA-dependent RNA polymerase and blocks"/>
  <result pre="RNA viruses including SARS/MERS-CoV. Other nucleoside analogues, such as favipiravir," exact="ribavirin" post="and galidesivir have also been suggested as potential treatments"/>
  <result pre="[70,71]. Studies supporting some role for broad-spectrum antiviral remdesivir and" exact="chloroquine" post="in COVID-19 were published [72–81]. Prolonged exposure to antiviral"/>
  <result pre="2020;395:1569–1578. doi: 10.1016/S0140-6736(20)31022-932423584 76QaseemA, YostJ, Etxeandia-IkobaltzetaI, et al.Should Clinicians Use" exact="chloroquine" post="or Hydroxychloroquine Alone or in Combination With Azithromycin for"/>
  <result pre="ValFFA, SampaioVS, et al.Effect of high vs low doses of" exact="chloroquine" post="Diphosphate as Adjunctive therapy for patients hospitalized With severe"/>
  <result pre="trial. JAMA Network Open. 2020;3:e208857. doi: 10.1001/jamanetworkopen.2020.8857 78PrincipiN, EspositoS.Chloroquine or" exact="hydroxychloroquine" post="for prophylaxis of COVID-19. Lancet Infect Dis. 2020;S1473-3099(20)30296-6. 79JakharD,"/>
  <result pre="prophylaxis of COVID-19. Lancet Infect Dis. 2020;S1473-3099(20)30296-6. 79JakharD, KaurI.Potential of" exact="chloroquine" post="and hydroxychloroquine to treat COVID-19 causes fears of shortages"/>
  <result pre="COVID-19. Lancet Infect Dis. 2020;S1473-3099(20)30296-6. 79JakharD, KaurI.Potential of chloroquine and" exact="hydroxychloroquine" post="to treat COVID-19 causes fears of shortages among people"/>
  <result pre="Nat Med. 2020;26:632. doi: 10.1038/s41591-020-0853-0 80YazdanyJ, KimAHJ.Use of Hydroxychloroquine and" exact="chloroquine" post="during the COVID-19 pandemic: What Every Clinician should Know."/>
  <result pre="Med. 2020;172(11):754–755. doi: 10.7326/M20-133432232419 81WangM, CaoR, ZhangL, et al.Remdesivir and" exact="chloroquine" post="effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in"/>
  <result pre="94StrikAS, BerendsSE, MouldDR, et al.Dashboard driven vs. conventional dosing of" exact="infliximab" post="in inflammatory bowel disease patients: the PRECISION trial. Journal"/>
 </snippets>
</snippetsTree>
